SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 77 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $55,000 | – | 13,440 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
KNOTT DAVID M | 158,400 | $459,000 | 0.20% |